Latest Articles
IVF live birth rate lower with deep infiltrating endometriosis, endometrioma - Healio
IVF live birth rate lower with deep infiltrating endometriosis, endometrioma Healio
Published: June 19, 2024, 7 a.m.
Shamita Shetty Undergoes Surgery For Endometriosis; Wants Women To Be Aware About This Condition | TheHeal - TheHealthSite
Shamita Shetty Undergoes Surgery For Endometriosis; Wants Women To Be Aware About This Condition | TheHeal TheHealthSite
Published: June 19, 2024, 7 a.m.
Dr. Roach: Debilitating menstrual pain might be due to endometriosis - Detroit News
Dr. Roach: Debilitating menstrual pain might be due to endometriosis Detroit News
Published: June 18, 2024, 7 a.m.
Androgen-responsive FOXP4 is a target for endometrial carcinoma | Communications Biology - Nature.com
Androgen-responsive FOXP4 is a target for endometrial carcinoma | Communications Biology Nature.com
Published: June 18, 2024, 7 a.m.
Two New Immunotherapy-Chemo Options Approved for Endometrial Cancer - Medpage Today
Two New Immunotherapy-Chemo Options Approved for Endometrial Cancer Medpage Today
Published: June 18, 2024, 7 a.m.
The spectrum of oestrogen receptor expression in endometrial carcinomas of no specific molecular profile - Wiley Online Library
The spectrum of oestrogen receptor expression in endometrial carcinomas of no specific molecular profile Wiley Online Library
Published: June 18, 2024, 7 a.m.
FDA approves MSD’s KEYTRUDA for endometrial carcinoma - Pharmaceutical Technology
FDA approves MSD’s KEYTRUDA for endometrial carcinoma Pharmaceutical Technology
Published: June 18, 2024, 7 a.m.
Novel immunotherapy combination approved for endometrial cancer - European Pharmaceutical Review
Novel immunotherapy combination approved for endometrial cancer European Pharmaceutical Review
Published: June 18, 2024, 7 a.m.
Merck's Keytruda snags 40th US indication, leaps ahead of GSK with broad endometrial cancer approval - FiercePharma
Merck's Keytruda snags 40th US indication, leaps ahead of GSK with broad endometrial cancer approval FiercePharma
Published: June 18, 2024, 7 a.m.
Merck’s Keytruda regimen granted FDA approval to treat endometrial cancer - PMLiVE
Merck’s Keytruda regimen granted FDA approval to treat endometrial cancer PMLiVE
Published: June 18, 2024, 7 a.m.
Link copied to clipboard!